Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular Support Catheter, expanding the company's stroke portfolio with a new large-bore catheter engineered for reliability, procedural flexibility, and physician control.

The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.

Building on over a decade of neurovascular catheter innovation, clinical success, and close collaboration with physicians, the SOFIA™ 88 Neurovascular Support Catheter delivers advanced performance through its 0.088-inch inner diameter and proprietary engineering enhancements. Designed for optimal trackability, it enables physicians to reach with confidence through complex anatomy using optimized transition zones and a soft, atraumatic distal tip.

The catheter also provides support to go the distance, offering proximal stability for procedural ease with both short and long sheaths. Additionally, its atraumatic design incorporates flexibility and reinforcement throughout the entire working length, minimizing vessel trauma and enabling smooth navigation.

"Terumo Neuro's SOFIA 88 Neurovascular Support Catheter is truly one of the best products in this category, especially when using a short 8F sheath," said Dr. Ameer Hassan, Head of Neuroscience Department at Valley Baptist, Professor of Neurology, University of Texas Rio Grande Valley. "It has great trackability and it is improving my access whether I decide to use it to support an aspiration only or a combination approach -- it really does improve my first pass effect."

"As we introduce the SOFIA™ 88 Neurovascular Support Catheter, we are building on a decade of performance that physicians around the world have come to trust," said Carsten Schroeder, President and CEO of Terumo Neuro. "This launch reflects our continued investment in neurovascular innovation, made possible through direct collaboration with physicians and our strong R&D and manufacturing capabilities. Together, we are delivering meaningful advancements in stroke care designed to improve outcomes for patients worldwide."

The SOFIA™ 88 Neurovascular Support Catheter is compatible with the SOFIA™ Flow Plus 6F Aspiration Catheter and supports integration into existing aspiration strategies. Clinical evidence from the SOFAST registry—evaluating the SOFIA™ Flow Plus 6F as a first-line approach—demonstrated strong results across speed, efficacy, and safety and overall clinical outcomes.